Over the coming months, Atyr Pharma will be working toward the launch of a global clinical trial testing its therapy candidate efzofitimod in people with moderate to severe pulmonary sarcoidosis and restrictive lung disease, which together make it difficult for the lungs to fully expand, hampering breathing. The…
Discussion
People with sarcoidosis but no documented liver involvement have a nearly threefold higher risk of developing permanent liver scarring (cirrhosis) than those without the inflammatory disease, according to a large, population-based study from Israel. The risk was particularly elevated among patients whose sarcoidosis affected multiple organs. Still, the absolute…
Discussion
At the start of a virtual meeting the other day, the facilitator began the discussion by asking all of us, “What are you grateful for?” Answers varied, but most included family, community, and health. I agree with those first two, but I have a harder time saying “thank you” to…
Becoming educated and informed about sarcoidosis is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your sarcoidosis journey.
There is no cure for sarcoidosis yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
